ID   CNOT7_HUMAN             Reviewed;         285 AA.
AC   Q9UIV1; A8MZM5; B3KMP1; B3KN35; D3DSP6; G3V108; Q7Z530;
DT   14-AUG-2001, integrated into UniProtKB/Swiss-Prot.
DT   02-FEB-2004, sequence version 3.
DT   22-JUL-2015, entry version 134.
DE   RecName: Full=CCR4-NOT transcription complex subunit 7;
DE            EC=3.1.13.4;
DE   AltName: Full=BTG1-binding factor 1;
DE   AltName: Full=CCR4-associated factor 1;
DE            Short=CAF-1;
DE   AltName: Full=Caf1a;
GN   Name=CNOT7; Synonyms=CAF1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=9820826;
RA   Bogdan J.A., Adams-Burton C., Pedicord D.L., Sukovich D.A.,
RA   Benfield P.A., Corjay M.H., Stoltenborg J.K., Dicker I.B.;
RT   "Human carbon catabolite repressor protein (CCR4)-associative factor
RT   1: cloning, expression and characterization of its interaction with
RT   the B-cell translocation protein BTG1.";
RL   Biochem. J. 336:471-481(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Wan Y.Z., Yu L., Zhang H.L., Liu Q., Chen S.Y., Zhao S.Y.;
RT   "Cloning and expression of a new human cDNA homology to mouse mCAF1
RT   protein mRNA.";
RL   Submitted (JUL-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Embryo, and Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S.,
RA   Garber M., Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A.,
RA   Chang J.L., Cuomo C.A., Dewar K., FitzGerald M.G., Yang X.,
RA   Allen N.R., Anderson S., Asakawa T., Blechschmidt K., Bloom T.,
RA   Borowsky M.L., Butler J., Cook A., Corum B., DeArellano K.,
RA   DeCaprio D., Dooley K.T., Dorris L. III, Engels R., Gloeckner G.,
RA   Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K., Jaffe D.B.,
RA   Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C.,
RA   O'Leary S.B., O'Neill K., Parker S.C.J., Polley A., Raymond C.K.,
RA   Reichwald K., Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R.,
RA   Smith C.L., Sneddon T.P., Talamas J.A., Tenzin P., Topham K.,
RA   Venkataraman V., Wen G., Yamazaki S., Young S.K., Zeng Q.,
RA   Zimmer A.R., Rosenthal A., Birren B.W., Platzer M., Shimizu N.,
RA   Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Prostate, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   CATALYTIC ACTIVITY.
RX   PubMed=15769875; DOI=10.1261/rna.7135305;
RA   Bianchin C., Mauxion F., Sentis S., Seraphin B., Corbo L.;
RT   "Conservation of the deadenylase activity of proteins of the Caf1
RT   family in human.";
RL   RNA 11:487-494(2005).
RN   [8]
RP   IDENTIFICATION IN THE CCR4-NOT COMPLEX, AND COMPOSITION OF THE
RP   CCR4-NOT COMPLEX.
RX   PubMed=19558367; DOI=10.1042/BJ20090500;
RA   Lau N.C., Kolkman A., van Schaik F.M., Mulder K.W., Pijnappel W.W.,
RA   Heck A.J., Timmers H.T.;
RT   "Human Ccr4-Not complexes contain variable deadenylase subunits.";
RL   Biochem. J. 422:443-453(2009).
RN   [9]
RP   FUNCTION.
RX   PubMed=19605561; DOI=10.1091/mbc.E09-02-0146;
RA   Aslam A., Mittal S., Koch F., Andrau J.C., Winkler G.S.;
RT   "The Ccr4-NOT deadenylase subunits CNOT7 and CNOT8 have overlapping
RT   roles and modulate cell proliferation.";
RL   Mol. Biol. Cell 20:3840-3850(2009).
RN   [10]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=20634287; DOI=10.1074/jbc.M110.150763;
RA   Cooke A., Prigge A., Wickens M.;
RT   "Translational repression by deadenylases.";
RL   J. Biol. Chem. 285:28506-28513(2010).
RN   [11]
RP   FUNCTION.
RX   PubMed=20065043; DOI=10.1128/MCB.01481-09;
RA   Piao X., Zhang X., Wu L., Belasco J.G.;
RT   "CCR4-NOT deadenylates mRNA associated with complexes in human
RT   cells.";
RL   Mol. Cell. Biol. 30:1486-1494(2010).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   FUNCTION, AND INTERACTION WITH TOB1 AND BTG2.
RX   PubMed=23236473; DOI=10.1371/journal.pone.0051331;
RA   Doidge R., Mittal S., Aslam A., Winkler G.S.;
RT   "The anti-proliferative activity of BTG/TOB proteins is mediated via
RT   the Caf1a (CNOT7) and Caf1b (CNOT8) deadenylase subunits of the Ccr4-
RT   not complex.";
RL   PLoS ONE 7:E51331-E51331(2012).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 11-262 IN COMPLEX WITH TOB1,
RP   CATALYTIC ACTIVITY, COFACTOR, AND MUTAGENESIS OF ASP-40; GLU-42;
RP   ASP-161; HIS-225 AND ASP-230.
RX   PubMed=19276069; DOI=10.1074/jbc.M809250200;
RA   Horiuchi M., Takeuchi K., Noda N., Muroya N., Suzuki T., Nakamura T.,
RA   Kawamura-Tsuzuku J., Takahasi K., Yamamoto T., Inagaki F.;
RT   "Structural basis for the antiproliferative activity of the Tob-hCaf1
RT   complex.";
RL   J. Biol. Chem. 284:13244-13255(2009).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 1-285 IN COMPLEX WITH CNOT1,
RP   AND MUTAGENESIS OF GLU-138; MET-141; THR-142 AND GLU-149.
RX   PubMed=22977175; DOI=10.1093/nar/gks883;
RA   Petit A.P., Wohlbold L., Bawankar P., Huntzinger E., Schmidt S.,
RA   Izaurralde E., Weichenrieder O.;
RT   "The structural basis for the interaction between the CAF1 nuclease
RT   and the NOT1 scaffold of the human CCR4-NOT deadenylase complex.";
RL   Nucleic Acids Res. 40:11058-11072(2012).
CC   -!- FUNCTION: Has 3'-5' poly(A) exoribonuclease activity for synthetic
CC       poly(A) RNA substrate. Its function seems to be partially
CC       redundant with that of CNOT8. Catalytic component of the CCR4-NOT
CC       complex which is one of the major cellular mRNA deadenylases and
CC       is linked to various cellular processes including bulk mRNA
CC       degradation, miRNA-mediated repression, translational repression
CC       during translational initiation and general transcription
CC       regulation. During miRNA-mediated repression the complex seems
CC       also to act as translational repressor during translational
CC       initiation. Additional complex functions may be a consequence of
CC       its influence on mRNA expression. Associates with members of the
CC       BTG family such as TOB1 and BTG2 and is required for their anti-
CC       proliferative activity. {ECO:0000269|PubMed:19605561,
CC       ECO:0000269|PubMed:20065043, ECO:0000269|PubMed:20634287,
CC       ECO:0000269|PubMed:23236473}.
CC   -!- CATALYTIC ACTIVITY: Exonucleolytic cleavage of poly(A) to 5'-AMP.
CC       {ECO:0000269|PubMed:15769875, ECO:0000269|PubMed:19276069,
CC       ECO:0000269|PubMed:20634287}.
CC   -!- COFACTOR:
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000269|PubMed:19276069};
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:19276069};
CC       Name=Co(2+); Xref=ChEBI:CHEBI:48828;
CC         Evidence={ECO:0000269|PubMed:19276069};
CC       Note=Binds 2 divalent metal cations per subunit with RNAase
CC       activity being higher in presence of Mn(2+) than of Mg(2+) or
CC       Co(2+). {ECO:0000269|PubMed:19276069};
CC   -!- SUBUNIT: Component of the CCR4-NOT complex; distinct complexes
CC       seem to exist that differ in the participation of probably
CC       mutually exclusive catalytic subunits; the complex contains two
CC       deadenylase subunits, CNOT6 or CNOT6L, and CNOT7 or CNOT8. In the
CC       complex, interacts directly with CNOT1. Interacts with AGO2, TOB1,
CC       BTG1, BTG2 and NANOS2. {ECO:0000269|PubMed:19276069,
CC       ECO:0000269|PubMed:19558367, ECO:0000269|PubMed:22977175,
CC       ECO:0000269|PubMed:23236473}.
CC   -!- INTERACTION:
CC       Q9UKV8:AGO2; NbExp=2; IntAct=EBI-2105113, EBI-528269;
CC       P62324:BTG1; NbExp=3; IntAct=EBI-2105113, EBI-742279;
CC       P78543:BTG2; NbExp=5; IntAct=EBI-2105113, EBI-1047576;
CC       A5YKK6:CNOT1; NbExp=6; IntAct=EBI-2105113, EBI-1222758;
CC       Q9ULM6:CNOT6; NbExp=2; IntAct=EBI-2105113, EBI-2104530;
CC       P50616:TOB1; NbExp=6; IntAct=EBI-2105113, EBI-723281;
CC       Q14106:TOB2; NbExp=3; IntAct=EBI-2105113, EBI-2562000;
CC       P22893:Zfp36 (xeno); NbExp=3; IntAct=EBI-2105113, EBI-647803;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Cytoplasm, P-body {ECO:0000250}.
CC       Note=NANOS2 promotes its localization to P-body. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9UIV1-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9UIV1-2; Sequence=VSP_045497;
CC         Note=No experimental confirmation available.;
CC   -!- SIMILARITY: Belongs to the CAF1 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAF01500.1; Type=Frameshift; Positions=4; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L46722; AAF01500.1; ALT_FRAME; mRNA.
DR   EMBL; AF086915; AAP97145.1; -; mRNA.
DR   EMBL; AK021808; BAG51053.1; -; mRNA.
DR   EMBL; AK023466; BAG51197.1; -; mRNA.
DR   EMBL; AC091050; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471080; EAW63820.1; -; Genomic_DNA.
DR   EMBL; CH471080; EAW63821.1; -; Genomic_DNA.
DR   EMBL; CH471080; EAW63822.1; -; Genomic_DNA.
DR   EMBL; CH471080; EAW63823.1; -; Genomic_DNA.
DR   EMBL; BC060852; AAH60852.1; -; mRNA.
DR   EMBL; BC070187; AAH70187.1; -; mRNA.
DR   CCDS; CCDS55202.1; -. [Q9UIV1-2]
DR   CCDS; CCDS6000.2; -. [Q9UIV1-1]
DR   RefSeq; NP_037486.2; NM_013354.5. [Q9UIV1-1]
DR   RefSeq; NP_473367.2; NM_054026.2. [Q9UIV1-2]
DR   RefSeq; XP_005273538.1; XM_005273481.2. [Q9UIV1-1]
DR   RefSeq; XP_011542813.1; XM_011544511.1. [Q9UIV1-1]
DR   UniGene; Hs.587465; -.
DR   UniGene; Hs.645009; -.
DR   UniGene; Hs.729775; -.
DR   PDB; 2D5R; X-ray; 2.50 A; A=11-262.
DR   PDB; 4GMJ; X-ray; 2.70 A; B/D/F=1-285.
DR   PDBsum; 2D5R; -.
DR   PDBsum; 4GMJ; -.
DR   ProteinModelPortal; Q9UIV1; -.
DR   SMR; Q9UIV1; 11-262.
DR   BioGrid; 118938; 38.
DR   DIP; DIP-41902N; -.
DR   IntAct; Q9UIV1; 24.
DR   MINT; MINT-155676; -.
DR   STRING; 9606.ENSP00000355279; -.
DR   PhosphoSite; Q9UIV1; -.
DR   BioMuta; CNOT7; -.
DR   DMDM; 41713629; -.
DR   MaxQB; Q9UIV1; -.
DR   PaxDb; Q9UIV1; -.
DR   PRIDE; Q9UIV1; -.
DR   DNASU; 29883; -.
DR   Ensembl; ENST00000361272; ENSP00000355279; ENSG00000198791.
DR   Ensembl; ENST00000523917; ENSP00000429093; ENSG00000198791. [Q9UIV1-2]
DR   GeneID; 29883; -.
DR   KEGG; hsa:29883; -.
DR   UCSC; uc003wxf.1; human. [Q9UIV1-1]
DR   UCSC; uc003wxh.1; human.
DR   CTD; 29883; -.
DR   GeneCards; GC08M017086; -.
DR   HGNC; HGNC:14101; CNOT7.
DR   MIM; 604913; gene.
DR   neXtProt; NX_Q9UIV1; -.
DR   PharmGKB; PA26678; -.
DR   eggNOG; COG5228; -.
DR   GeneTree; ENSGT00390000000080; -.
DR   HOGENOM; HOG000173077; -.
DR   HOVERGEN; HBG051044; -.
DR   InParanoid; Q9UIV1; -.
DR   KO; K12581; -.
DR   OMA; KYSGHLY; -.
DR   OrthoDB; EOG74BJSP; -.
DR   PhylomeDB; Q9UIV1; -.
DR   TreeFam; TF314185; -.
DR   Reactome; REACT_20514; Deadenylation of mRNA.
DR   ChiTaRS; CNOT7; human.
DR   EvolutionaryTrace; Q9UIV1; -.
DR   GeneWiki; CNOT7; -.
DR   GenomeRNAi; 29883; -.
DR   NextBio; 52417; -.
DR   PRO; PR:Q9UIV1; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; Q9UIV1; -.
DR   CleanEx; HS_CNOT7; -.
DR   ExpressionAtlas; Q9UIV1; baseline and differential.
DR   Genevisible; Q9UIV1; HS.
DR   GO; GO:0030014; C:CCR4-NOT complex; IDA:UniProtKB.
DR   GO; GO:0000932; C:cytoplasmic mRNA processing body; ISS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0000175; F:3'-5'-exoribonuclease activity; IDA:UniProtKB.
DR   GO; GO:0004532; F:exoribonuclease activity; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004535; F:poly(A)-specific ribonuclease activity; IDA:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0003700; F:sequence-specific DNA binding transcription factor activity; TAS:ProtInc.
DR   GO; GO:0004871; F:signal transducer activity; TAS:ProtInc.
DR   GO; GO:0005975; P:carbohydrate metabolic process; TAS:ProtInc.
DR   GO; GO:0033962; P:cytoplasmic mRNA processing body assembly; IEA:Ensembl.
DR   GO; GO:0000290; P:deadenylation-dependent decapping of nuclear-transcribed mRNA; IEA:Ensembl.
DR   GO; GO:0043928; P:exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay; IDA:UniProtKB.
DR   GO; GO:0010467; P:gene expression; TAS:Reactome.
DR   GO; GO:0035195; P:gene silencing by miRNA; TAS:UniProtKB.
DR   GO; GO:0031047; P:gene silencing by RNA; ISS:UniProtKB.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; IDA:UniProtKB.
DR   GO; GO:0010629; P:negative regulation of gene expression; IMP:BHF-UCL.
DR   GO; GO:0000288; P:nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; TAS:Reactome.
DR   GO; GO:0000289; P:nuclear-transcribed mRNA poly(A) tail shortening; TAS:Reactome.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; IMP:UniProtKB.
DR   GO; GO:0061014; P:positive regulation of mRNA catabolic process; IMP:BHF-UCL.
DR   GO; GO:1900153; P:positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; IMP:UniProtKB.
DR   GO; GO:0060213; P:positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; IMP:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl.
DR   GO; GO:0006417; P:regulation of translation; IEA:UniProtKB-KW.
DR   GO; GO:0090503; P:RNA phosphodiester bond hydrolysis, exonucleolytic; IDA:GOC.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   Gene3D; 3.30.420.10; -; 1.
DR   InterPro; IPR006941; RNase_CAF1.
DR   InterPro; IPR012337; RNaseH-like_dom.
DR   Pfam; PF04857; CAF1; 1.
DR   SUPFAM; SSF53098; SSF53098; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; Cytoplasm;
KW   Exonuclease; Hydrolase; Magnesium; Metal-binding; Nuclease; Nucleus;
KW   Reference proteome; Repressor; RNA-binding;
KW   RNA-mediated gene silencing; Transcription; Transcription regulation;
KW   Translation regulation.
FT   CHAIN         1    285       CCR4-NOT transcription complex subunit 7.
FT                                /FTId=PRO_0000212844.
FT   METAL        40     40       Divalent metal cation 1; catalytic.
FT                                {ECO:0000305}.
FT   METAL        40     40       Divalent metal cation 2; catalytic.
FT                                {ECO:0000305}.
FT   METAL        42     42       Divalent metal cation 2; catalytic.
FT                                {ECO:0000305}.
FT   METAL       161    161       Divalent metal cation 1; catalytic.
FT                                {ECO:0000305}.
FT   METAL       230    230       Divalent metal cation 2; catalytic.
FT                                {ECO:0000305}.
FT   METAL       278    278       Divalent metal cation 1; catalytic.
FT                                {ECO:0000305}.
FT   VAR_SEQ     244    285       MFFEDHIDDAKYCGHLYGLGSGSSYVQNGTGNAYEEEANKQ
FT                                S -> V (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045497.
FT   MUTAGEN      40     40       D->N: Abolishes RNA deadenylase activity.
FT                                {ECO:0000269|PubMed:19276069}.
FT   MUTAGEN      42     42       E->Q: Abolishes RNA deadenylase activity.
FT                                {ECO:0000269|PubMed:19276069}.
FT   MUTAGEN     138    138       E->K: Abolishes interaction with CNOT1;
FT                                when associated with Y-142 and K-149.
FT                                {ECO:0000269|PubMed:22977175}.
FT   MUTAGEN     141    141       M->R: Abolishes interaction with CNOT1.
FT                                {ECO:0000269|PubMed:22977175}.
FT   MUTAGEN     142    142       T->Y: Abolishes interaction with CNOT1;
FT                                when associated with K-138 and K-149.
FT                                {ECO:0000269|PubMed:22977175}.
FT   MUTAGEN     149    149       E->K: Abolishes interaction with CNOT1;
FT                                when associated with K-138 and Y-142.
FT                                {ECO:0000269|PubMed:22977175}.
FT   MUTAGEN     161    161       D->N: Abolishes RNA deadenylase activity.
FT                                {ECO:0000269|PubMed:19276069}.
FT   MUTAGEN     203    203       K->A: Abolishes interaction with TOB1.
FT   MUTAGEN     225    225       H->A: Abolishes RNA deadenylase activity.
FT                                {ECO:0000269|PubMed:19276069}.
FT   MUTAGEN     230    230       D->N: Abolishes RNA deadenylase activity.
FT                                {ECO:0000269|PubMed:19276069}.
FT   CONFLICT      4      5       AT -> EL (in Ref. 3; AAP97145).
FT                                {ECO:0000305}.
FT   CONFLICT    241    241       M -> V (in Ref. 4; BAG51197).
FT                                {ECO:0000305}.
FT   STRAND       12     15       {ECO:0000244|PDB:2D5R}.
FT   HELIX        17     19       {ECO:0000244|PDB:2D5R}.
FT   HELIX        20     33       {ECO:0000244|PDB:2D5R}.
FT   STRAND       36     42       {ECO:0000244|PDB:2D5R}.
FT   HELIX        57     69       {ECO:0000244|PDB:2D5R}.
FT   STRAND       76     82       {ECO:0000244|PDB:2D5R}.
FT   STRAND       94     99       {ECO:0000244|PDB:2D5R}.
FT   TURN        103    105       {ECO:0000244|PDB:2D5R}.
FT   HELIX       110    119       {ECO:0000244|PDB:2D5R}.
FT   HELIX       123    129       {ECO:0000244|PDB:2D5R}.
FT   HELIX       133    141       {ECO:0000244|PDB:2D5R}.
FT   TURN        142    144       {ECO:0000244|PDB:2D5R}.
FT   STRAND      145    150       {ECO:0000244|PDB:2D5R}.
FT   STRAND      152    157       {ECO:0000244|PDB:2D5R}.
FT   HELIX       159    170       {ECO:0000244|PDB:2D5R}.
FT   HELIX       178    188       {ECO:0000244|PDB:2D5R}.
FT   STRAND      192    194       {ECO:0000244|PDB:2D5R}.
FT   HELIX       195    198       {ECO:0000244|PDB:2D5R}.
FT   HELIX       199    201       {ECO:0000244|PDB:2D5R}.
FT   HELIX       209    216       {ECO:0000244|PDB:2D5R}.
FT   HELIX       227    244       {ECO:0000244|PDB:2D5R}.
FT   HELIX       252    255       {ECO:0000244|PDB:2D5R}.
SQ   SEQUENCE   285 AA;  32745 MW;  2AF23ED27E06EFDB CRC64;
     MPAATVDHSQ RICEVWACNL DEEMKKIRQV IRKYNYVAMD TEFPGVVARP IGEFRSNADY
     QYQLLRCNVD LLKIIQLGLT FMNEQGEYPP GTSTWQFNFK FNLTEDMYAQ DSIELLTTSG
     IQFKKHEEEG IETQYFAELL MTSGVVLCEG VKWLSFHSGY DFGYLIKILT NSNLPEEELD
     FFEILRLFFP VIYDVKYLMK SCKNLKGGLQ EVAEQLELER IGPQHQAGSD SLLTGMAFFK
     MREMFFEDHI DDAKYCGHLY GLGSGSSYVQ NGTGNAYEEE ANKQS
//
